Medicare
Advantage: Hype or Hope for Community Pharmacy?
Please
read through the following information and click continue.
ACPE Universal Program Number:
207-000-09-021-H04-P
and 207-000-09-021-H04-T
Release
Date: February 23, 2009
Expiration Date: February 23, 2012
Statement
of Need
It
is no secret that plan participation and enrollment in Medicare managed
care programs has fluctuated over the past 30 years. However, now with
one in five Medicare patients now enrolled in a Medicare Advantage
plan, it's more than just hype and fancy marketing. And with three
years of experience behind us, Medicare is already looking beyond PDPs
as the solution for its long-term sustainability. Unlike PDPs that face
constant pressure to reduce drug spend, often by cutting pharmacy
reimbursement, MAPDs have a built-in incentive to manage the total
health of the patient. It is imperative that pharmacy is ready to
embrace this new benefit model.
It's important for pharmacists to understand the real, tangible benefits of Medicare Advantage—both to their patients and their pharmacy. Find out what pharmacies can be doing to ensure a solid position in the Medicare Advantage market, what questions to ask when contracting with Medicare Advantage plans, and what role pharmacists can play in this managed care model.
Learning
Objectives
Upon
successful completion of this activity, the pharmacist should be able
to:
- Explain the difference between Medicare Prescription Drug Plans (PDPs) and Medicare Advantage Prescription Drug Plans (MAPDs).
- Discuss the role pharmacists can play in the management of chronic care patients within the Medicare Advantage Program.
- List and explain the factors that pharmacists should consider when contracting with a Medicare Advantage Plan.
Target
Audience
The
target market for this activity is pharmacists and pharmacy technicians.
Instructions
for Participation
To
receive a certificate of completion that indicates your eligibility for
continuing education credit, you must:
- Review the content of the activity.
- Successfully complete the post-test (70% or higher).
- You will have two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee
There
is no fee for this activity.
Accreditation
Pharmacists
NCPA is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
This activity will provide 1.0 contact hours (.10 CEUs) of continuing
pharmacy education credit under the number 207-000-09-021-H04-P
and 207-000-09-021-H04-T.
Faculty
Abby
L. Block (click here to view bio)
Director, Center for Drug and Health Plan Choice
Center for Medicare & Medicaid Services (CMS)
Washington, DC
Tim Davis, RPh (click here to view bio)
Owner
Beaver Health Mart Pharmacy
Beaver Falls, PA
Disclosure
Declaration
It
is the policy of the National Community Pharmacists Association (NCPA)
to ensure independence, balance, objectivity, scientific rigor, and
integrity in all of their continuing education activities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Commercial Support Statement
 |
Commercial support provided by Community CCRx.
Software Requirements
|
PC *Required to view Printable PDF Version |
MAC |